Clinical Trial Update: Treatment With MK0966 for the Prevention of Prostate Cancer (0966-201) [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating MK0966 for the prevention of prostate cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• MK0966

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Prostate Cancer | Phase 3 | Status: COMPLETED